Healthcare provider profile · identity verified

Judith Anne Connell, ANP-C

Nurse Practitioner · SPARTA, NJ · NPI 1780157313

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	47
Amlodipine Besylate	Amlodipine Besylate	396	33
Gabapentin	Gabapentin	341	26
Metformin Hcl	Metformin Hcl	291	23
Pantoprazole Sodium	Pantoprazole Sodium	258	25
Levothyroxine Sodium	Levothyroxine Sodium	224	21
Tamsulosin Hcl	Tamsulosin Hcl	207	21
Furosemide	Furosemide	196	20
Eliquis	Apixaban	190	15
Trazodone Hcl	Trazodone Hcl	185	22
Lisinopril	Lisinopril	163	15
Metoprolol Succinate	Metoprolol Succinate	159	16
Omeprazole	Omeprazole	151	12
Sertraline Hcl	Sertraline Hcl	150	12
Famotidine	Famotidine	140	16
Losartan Potassium	Losartan Potassium	130	13
Quetiapine Fumarate	Quetiapine Fumarate	130	14
Levetiracetam	Levetiracetam	125	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	122	11
Clopidogrel	Clopidogrel Bisulfate	120	13
Metoprolol Tartrate	Metoprolol Tartrate	116	11
Aripiprazole	Aripiprazole	113	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	112	suppressed
Potassium Chloride	Potassium Chloride	111	suppressed
Mirtazapine	Mirtazapine	110	16
Carvedilol	Carvedilol	104	11
Divalproex Sodium	Divalproex Sodium	102	suppressed
Simvastatin	Simvastatin	98	suppressed
Lamotrigine	Lamotrigine	92	suppressed
Risperidone	Risperidone	91	suppressed
Meloxicam	Meloxicam	88	11
Fluoxetine Hcl	Fluoxetine Hcl	81	suppressed
Finasteride	Finasteride	76	suppressed
Olanzapine	Olanzapine	74	suppressed
Tradjenta	Linagliptin	66	suppressed
Metformin Hcl Er	Metformin Hcl	63	suppressed
Hydralazine Hcl	Hydralazine Hcl	59	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	54	suppressed
Amantadine	Amantadine Hcl	53	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	53	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	49	17
Donepezil Hcl	Donepezil Hcl	48	suppressed
Sucralfate	Sucralfate	48	suppressed
Jardiance	Empagliflozin	47	suppressed
Montelukast Sodium	Montelukast Sodium	47	suppressed
Lithium Carbonate	Lithium Carbonate	45	suppressed
Myrbetriq	Mirabegron	44	suppressed
Baclofen	Baclofen	41	suppressed
Naproxen	Naproxen	41	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	37	13
Bupropion Xl	Bupropion Hcl	37	suppressed
Hydrocortisone	Hydrocortisone	37	suppressed
Midodrine Hcl	Midodrine Hcl	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	21
Allopurinol	Allopurinol	35	suppressed
Oxcarbazepine	Oxcarbazepine	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Colestipol Hcl	Colestipol Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Prednisone	Prednisone	31	suppressed
Calcium Acetate	Calcium Acetate	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Varenicline Tartrate	Varenicline Tartrate	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	15
Vascepa	Icosapent Ethyl	28	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	27	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Haloperidol	Haloperidol	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Entacapone	Entacapone	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Tiadylt Er	Diltiazem Hcl	18	suppressed
Zonisamide	Zonisamide	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Prezcobix	Darunavir/Cobicistat	17	suppressed
Topiramate	Topiramate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Repaglinide	Repaglinide	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Tacrolimus	Tacrolimus	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Glipizide	Glipizide	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error